Our company news

August news at Smooth Drug Development

We are glad to present you a brief overview of the major company events for July: Our company starts the following new activities:Smooth is preparing to start monitoring activities in phase III study of INN: Darbepoetin alfa

Smooth Drug Development are happy to present June newsletter Smooth has started several new clinical trial projects in June

We are working on the following new projects:Smooth signed a new contract for data management in a phase III clinical trial of INN: Darbepoetin alfa

Smooth Drug Development provides a full range of clinical trial services in Central and Eastern Europe

Other news of this month: Our business development team is preparing for a tour of conferences and will visit MAGI, ASCO, and BIO in May and June of this year

The company has reached important milestones in the following projects: Our team screened the first patient in the AML study, sponsored by an international company

Our company is preparing to launch a phase III trial in ADHDSmooth was awarded with phase III trial in sinusitis, sponsored by a global companyOur company was awarded with observational study in prostatitis

Our Corporate development group visited several important conventions:On January 6-11, our business development team in the attended the JPM week in San Francisco

This year we are bringing our BD team, so there should be no problems with scheduling appointments

It was a pleasure to participate in discussions of the best haematology and oncology specialists from the entire planet

Smooth reached an agreement with a global company for research report adaptation for a publication and data processing and medical writing for a current study

On October 2-4, Smooth Drug Development visited Outsourcing in Clinical Trials, Mid-Atalantic, in Silver Spring

We reached important milestones in the following projects:Smooth clinical team received an approval for conduct of a trial of an innovative orphan drug in ALD